|
|
Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus
Lucas Guillo
,
Pierre Delanaye
,
Martin Flamant
,
Lucile Figueres
,
Sabine Karam
et al.
Journal articles
hal-03519669v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Determinants of IBD-related disability: a cross-sectional survey from the GETAID.
Jenny Tannoury
,
Maria Nachury
,
Carole Martins
,
Melanie Serrero
,
Jerome Filippi
et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (10), pp.1098-1107. ⟨10.1111/apt.16353⟩
Journal articles
hal-03216615v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.
Guillaume Bouguen
,
Jean-Baptiste Chevaux
,
Laurent Peyrin-Biroulet
Journal articles
hal-01134847v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and Safety of Adalimumab 80 mg Weekly in Luminal Crohn's Disease.
Guillaume Bouguen
,
David Laharie
,
Stéphane Nancey
,
Xavier Hebuterne
,
Bernard Flourie
et al.
Journal articles
hal-01138534v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
Loriane Lair-Mehiri
,
Carmen Stefanescu
,
Thibaut Vaysse
,
David Laharie
,
Xavier Roblin
et al.
Journal articles
hal-03287300v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Tu1940 Patients' Point of View Regarding Acceptability and Usefulness of Inflammatory Bowel Diseases Monitoring Tools: Results From a Nationwide Multicenter Study (the ACCEPT Study)
Anthony Buisson
,
Florent Gonzalez
,
Florian Poullenot
,
Stephane Nancey
,
Elisa Sollelis
et al.
Journal articles
hal-01335055v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease.
Guillaume Bouguen
,
Barrett G. Levesque
,
Brian G. Feagan
,
Arthur Kavanaugh
,
Laurent Peyrin-Biroulet
et al.
Journal articles
hal-00878688v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
Mathurin Fumery
,
Jerome Filippi
,
Vered Abitbol
,
Amelie Biron
,
David Laharie
et al.
Journal articles
hal-03336375v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
Aurelien Amiot
,
Jerome Filippi
,
Vered Abitbol
,
Guillaume Cadiot
,
David Laharie
et al.
Journal articles
hal-02798010v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Compared efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study
Marianne Hupe
,
Pauline Riviere
,
Stephane Nancey
,
Xavier Roblin
,
Romain Altwegg
et al.
Journal articles
hal-02562228v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis
Guillaume Pineton de Chambrun
,
Aurélien Amiot
,
Guillaume Bouguen
,
Stéphanie Viennot
,
Romain Altwegg
et al.
Journal articles
hal-02179668v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence of anti-TNF contraindications in Crohn’s disease: A cross-sectional survey from the GETAID
Aurelien Amiot
,
Philippe Seksik
,
Jean-Marie Reimund
,
Maria Nachury
,
Romain Altwegg
et al.
Journal articles
hal-03690498v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study
Laurent Peyrin-Biroulet
,
Guillaume Bouguen
,
David Laharie
,
Gauthier Pellet
,
Guillaume Savoye
et al.
Journal articles
hal-03657045v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease.
Anthony Lopez
,
Morgane Mounier
,
Anne-Marie Bouvier
,
Fabrice Carrat
,
Marc Maynadié
et al.
Journal articles
hal-00955200v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study
Anne-Laure Mallet
,
Guillaume Bouguen
,
Guillaume Conroy
,
Xavier Roblin
,
Jean-Bernard Delobel
et al.
Journal articles
hal-01483854v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients with Inflammatory Bowel Disease
Aurelien Amiot
,
Jean-Charles Grimaud
,
Laurent Peyrin-Biroulet
,
Jérome Filippi
,
Benjamin Pariente
et al.
Journal articles
hal-01278611v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study
Antoine Martin
,
Maria Nachury
,
Laurent Peyrin-Biroulet
,
Yoram Bouhnik
,
Stephane Nancey
et al.
Journal articles
hal-02442530v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti-Tumor Necrosis Factor Agents
Pauline Wils
,
Yoram Bouhnik
,
Pierre Michetti
,
Bernard Flourie
,
Hedia Brixi
et al.
Journal articles
hal-01214012v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID
Doriane Broussard
,
Pauline Riviere
,
Joelle Bonnet
,
Ginette Fotsing
,
Aurelien Amiot
et al.
Journal articles
hal-03228852v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients
Constance Chapuis-Biron
,
Anne Bourrier
,
Maria Nachury
,
Stephane Nancey
,
Yoram Bouhnik
et al.
Journal articles
hal-03228900v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|